Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 601–700 of 1,009
The application of artificial intelligence in diabetic retinopathy: progress and prospects
Xu, X., Zhang, M., Huang, S., Li, X., Kui, X., & Liu, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1473176 · Cited by 35
Qiao, Z., Pan, X., Parlayan, C., Ojima, H., & Kondo, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.09.011 · Cited by 31
Base‐Modified Nucleic Acids as a Powerful Tool for Synthetic Biology and Biotechnology
Eremeeva, E., Abramov, M., Margamuljana, L., & Herdewijn, P. A. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201700679 · Cited by 30
High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
Narzo, A. D., Brodmerkel, C. M., Telesco, S., Argmann, C., Peters, L. A., Li, K., Kidd, B. A., Dudley, J. T., Cho, J. H., Schadt, E. E., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy190 · Cited by 33
Vero Cell Proteomic Changes Induced by Zika Virus Infection
Glover, K. K. M., Gao, A., Amiri, A. Z., & Coombs, K. M. (2018) · PROTEOMICS · doi:10.1002/pmic.201800309 · Cited by 31
Mimicking Chemotactic Cell Migration with DNA Programmable Synthetic Vesicles
Pan, J., Du, Y., Qiu, H., Upton, L. R., Li, F., & Choi, J. H. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b04428 · Cited by 30
Proteomic biomarkers of sleep apnea
Ambati, A., Ju, Y. S., Lin, L., Olesen, A. N., Koch, H., Hedou, J. J., Leary, E. B., Sempere, V. P., Mignot, E. J.-M., & Taheri, S. (2020) · SLEEP · doi:10.1093/sleep/zsaa086 · Cited by 32
Finding a Needle in a Haystack
Michelhaugh, S. A., & Januzzi, J. L. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.07.007 · Cited by 33
“However, instead of using antibodies, short, tightly wrapped oligonucleotide strands called aptamers bind to the proteins (11,28).”
BackgroundComparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients
Liu, R. X., Thiessen‐Philbrook, H., Vasan, R. S., Coresh, J., Ganz, P., Bonventre, J. V., Kimmel, P. L., & Parikh, C. R. (2021) · Translational research · doi:10.1016/j.trsl.2021.07.005 · Cited by 32
Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review
Rojo, A. C., Heylen, D., Aerts, J. A., Thas, O., Hooyberghs, J., Ertaylan, G., & Valkenborg, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.723510 · Cited by 34
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study
Echouffo-Tcheugui, J. B., Daya, N. R., Ndumele, C. E., Matsushita, K., Hoogeveen, R. C., Ballantyne, C. M., Coresh, J., Shah, A. M., & Selvin, E. (2022) · Diabetologia · doi:10.1007/s00125-022-05678-6 · Cited by 35
Modulation of BACE1 Activity by Chemically Modified Aptamers
Gasse, C., Zaarour, M., Noppen, S., Abramov, M., Marlière, P., Liekens, S., Strooper, B. D., & Herdewijn, P. A. (2018) · ChemBioChem · doi:10.1002/cbic.201700461 · Cited by 31
Yang, C., Farias, F. G., Ibáñez, L., Sadler, B. E., Fernández, M. V., Wang, F., Bradley, J. L., Eiffert, B., Bahena, J. A., Budde, J., et al. (2020) · medRxiv · doi:10.1101/2020.06.25.20140277 · Cited by 32
Functional Selection of Tau Oligomerization‐Inhibiting Aptamers
Wang, B., Pan, X., Teng, I., Li, X., Kobeissy, F. H., Wu, Z., Zhu, J., Cai, G., Yan, H., Yan, X., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202402007 · Cited by 36
Schilling, K. B., DeGrasse, J. A., & Woods, J. W. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.03.054 · Cited by 29
Plasma proteome in multiple sclerosis disease progression
Malekzadeh, A., Leurs, C. E., van Wieringen, W. N., Steenwijk, M. D., Schoonheim, M. M., Amann, M., Naegelin, Y., Kühle, J., Killestein, J., & Teunissen, C. E. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.771 · Cited by 32
Virus-based SELEX (viro-SELEX) allows development of aptamers targeting knotty proteins
Narayan, C., Kwon, J., Kim, C., Kim, S., & Jang, S. K. (2020) · The Analyst · doi:10.1039/c9an01943j · Cited by 32
Toyoda, E., Sato, M., Takahashi, T., Maehara, M., Okada, E., Wasai, S., Iijima, H., Nonaka, K., Kawaguchi, Y., & Watanabe, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010149 · Cited by 29
Identifying Protein–metabolite Networks Associated with COPD Phenotypes
Mastej, E. J., Gillenwater, L. A., Zhuang, Y., Pratte, K., Bowler, R. P., & Kechris, K. J. (2020) · Metabolites · doi:10.3390/metabo10040124 · Cited by 35
Liu, Y., Le, C., Tyrrell, D. L., Le, X. C., & Li, X. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05740 · Cited by 29
In Vitro Selection of an ATP-Binding TNA Aptamer
Zhang, L., & Chaput, J. C. (2020) · Molecules · doi:10.3390/molecules25184194 · Cited by 32
Takanashi, S., Kikuchi, J., Sasaki, T., Akiyama, M., Yasuoka, H., Yoshimoto, K., Seki, N., Sugahara, K., Chiba, K., Kaneko, Y., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa648 · Cited by 32
Predicting the probability of death using proteomics
Eiriksdottir, T., Ardal, S., Jonsson, B. A., Lund, S. H., Ivarsdottir, E. V., Norland, K., Ferkingstad, E., Stefansson, H., Jonsdottir, I., Holm, H., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02289-6 · Cited by 30
Yoon, J. W., Jang, I. H., Heo, S. C., Kwon, Y. W., Choi, E. J., Bae, K., Suh, D. S., Kim, S.-C., Han, S., Haam, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131785 · Cited by 29
Cronjé, H. T., Mi, M., Austin, T. R., Biggs, M. L., Siscovick, D. S., Lemaître, R. N., Psaty, B. M., Tracy, R. P., Djoussé, L., Kizer, J. R., et al. (2023) · Diabetes · doi:10.2337/db22-0628 · Cited by 34
Systems genetics approaches for understanding complex traits with relevance for human disease
Allayee, H., Farber, C. R., Seldin, M. M., Williams, E. G., James, D. E., & Lusis, A. J. (2023) · eLife · doi:10.7554/elife.91004 · Cited by 37
RNA plasticity and selectivity applicable to therapeutics and novel biosensor development
Nakamura, Y., Ishiguro, A., & Miyakawa, S. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2012.01596.x · Cited by 33
Post-translational modifications in tumor biomarkers: the next challenge for aptamers?
Díaz‐Fernández, A., Miranda‐Castro, R., de-los-Santos-Álvarez, N., & Lobo-Castañón, M. J. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-0861-9 · Cited by 29
Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction
Gui, H., She, R., Luzum, J. A., Li, J., Bryson, T. D., Pinto, Y. M., Sabbah, H. N., Williams, L. K., & Lanfear, D. E. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003140 · Cited by 32
Serum protein biomarkers for juvenile dermatomyositis: a pilot study
Tawalbeh, S. M., Marin, W., Morgan, G. A., Dang, U. J., Hathout, Y., & Pachman, L. M. (2020) · BMC Rheumatology · doi:10.1186/s41927-020-00150-7 · Cited by 32
“The technique has been described in more details elsewhere [23, 24] and consists of a panel of protein-specific Slow Off-rate Modified DNA aptamers (SOMAmers) that bind with high specificity and affinity to target proteins.”
MethodTorres-Vázquez, B., de Lucas, A. M., García‐Crespo, C., García-Martín, J. A., Fragoso-Luna, A., Fernández-Algar, M., Perales, C., Domingo, E., Moreno, M., & Briones, C. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167501 · Cited by 28
Perinatal mood and anxiety disorders: biomarker discovery using plasma proteomics
Accortt, E. E., Mirocha, J., Zhang, D., Kilpatrick, S. J., Libermann, T. A., & Karumanchi, S. A. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.01.012 · Cited by 31
Aptamers in immunological research
Nezlin, R. S. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.001 · Cited by 28
Parolo, S., Marchetti, L., Lauria, M., Misselbeck, K., Scott‐Boyer, M., Caberlotto, L., & Priami, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194225 · Cited by 37
Increased levels of circulating MMP3 correlate with severe rejection in face transplantation
Kollár, B., Shubin, A. V., Borges, T. J., Tasigiorgos, S., Win, T. S., Lian, C. G., Dillon, S. T., Gu, X., Wyrobnik, I., Murphy, G. F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33272-7 · Cited by 32
Trends in Aptasensing and the Enhancement of Diagnostic Efficiency and Accuracy
Ansari, M. A., Verma, D., Hamizan, M., Mukherjee, M. D., Mohd‐Naim, N. F., & Ahmed, M. U. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00591 · Cited by 30
Expansion of the aptamer library from a "natural soup" to an "unnatural soup".
Uzawa, T., Tada, S., Wang, W., & Ito, Y. (2013) · Chemical Communications · doi:10.1039/c2cc36348h · Cited by 25
Workman, A. D., Nocera, A. L., Mueller, S. K., Otu, H. H., Libermann, T. A., & Bleier, B. S. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22315 · Cited by 31
Lee, S., Kang, I. K., Kim, J. H., Jung, B. K., Park, K., Chang, H., Lee, J. Y., & Lee, H. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.2.14 · Cited by 27
Daniels, J. R., Cao, Z., Maisha, M. P., Schnackenberg, L. K., Sun, J., Pence, L. M., Schmitt, T. C., Kamlage, B., Rogstad, S., Beger, R. D., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00320 · Cited by 32
Modified nucleotides may have enhanced early RNA catalysis
Wolk, S. K., Mayfield, W. S., Gelinas, A. D., Astling, D. P., Guillot, J., Brody, E. N., Janjić, N., & Gold, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809041117 · Cited by 27
Self-citationGeorge, M. J., Kleveland, O., García-Hernández, J., Palmen, J., Lovering, R. C., Wiseth, R., Aukrust, P., Engmann, J., Damås, J. K., Hingorani, A. D., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015628 · Cited by 27
Idemoto, K., Ishima, T., Niitsu, T., Hata, T., Yoshida, S., Hattori, K., Horai, T., Otsuka, I., Yamamori, H., Toda, S., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.051 · Cited by 31
Bersell, K. R., Yang, T., Mosley, J. D., Glazer, A. M., Hale, A. T., Kryshtal, D. O., Kim, K., Steimle, J. D., Brown, J. D., Salem, J., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.062193 · Cited by 26
Ahsan, N., Fornelli, L., Najar, F. Z., Gamagedara, S., Hossan, M. R., Rao, R. S. P., Punyamurtula, U., Bauer, A. M., Yang, Z., Foster, S. B., et al. (2023) · PROTEOMICS · doi:10.1002/pmic.202300150 · Cited by 31
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivo
Geretz, A., Ehrenberg, P. K., Clifford, R., Laliberté, A., Bozzo, C. P., Eiser, D., Kundu, G., Yum, L. K., Apps, R., Creegan, M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg0873 · Cited by 29
Kimoto, M., Matsunaga, K., & Hirao, I. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3197-2_4 · Cited by 27
Respiratory Mucosal Proteome Quantification in Human Influenza Infections
Marion, T. N., Elbahesh, H., Thomas, P. G., DeVincenzo, J. P., Webby, R. J., & Schughart, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153674 · Cited by 29
Pulmonary Aptamer Signatures in Children’s Interstitial and Diffuse Lung Disease
Deterding, R. R., Wagner, B. D., Harris, J. K., & DeBoer, E. M. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0547oc · Cited by 29
“SomaScan Proteomics Platform The SomaScan platform using SOMAmer (Slow Off-rate Modified Aptamer) reagents can sensitively screen over 1,000 proteins (18).”
BackgroundMethodInfluentialTorshizi, A. D., Truong, D. T., Hou, L., Smets, B., Whelan, C. D., & Li, S. (2024) · Nature Communications · doi:10.1038/s41467-024-50718-x · Cited by 28
Secretome Analysis Using Affinity Proteomics and Immunoassays: A Focus on Tumor Biology
Beutgen, V. M., Shinkevich, V. A., Pörschke, J., Meena, C., Steitz, A. M., von Strandmann, E. P., Graumann, J., & Gómez‐Serrano, M. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100830 · Cited by 31
Nucleic Acid Aptamers for Living Cell Analysis
Xiong, X., Lv, Y., Chen, T., Zhang, X., Wang, K., & Tan, W. (2014) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071213-015944 · Cited by 26
Web Tool for Navigating and Plotting SomaLogic ADAT Files
Cheung, F., Fantoni, G., Conner, M., Sellers, B. A., Kotliarov, Y., Candia, J., Stagliano, K. E., & Biancotto, A. (2017) · Journal of Open Research Software · doi:10.5334/jors.166 · Cited by 26
Guerrero, C. L. H., Yamashita, Y., Miyara, M., Imaizumi, N., Kato, M., Sakihama, S., Hayashi, M., Miyagi, T., Karimata, K., Uchihara, J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001429 · Cited by 27
Norby, F. L., Tang, W., Pankow, J. S., Lutsey, P. L., Alonso, Á., Steffen, B. T., Chen, L. Y., Zhang, M. J., Shippee, N. D., Ballantyne, C. M., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.064 · Cited by 27
Wu, X., Jeong, Y., Poli, S., Easthausen, I. J., Hoffman, K., Oromendia, C., Taheri, S., Esposito, A. J., Quesada-Arias, L. D., Ayaub, E. A., et al. (2022) · Thorax · doi:10.1136/thorax-2021-217822 · Cited by 29
Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction
Javaheri, A., Diab, A., Zhao, L., Qian, C., Cohen, J. B., Zamani, P. L., Kumar, A., Wang, Z., Ebert, C., Maranville, J., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009693 · Cited by 27
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
Agnello, L., d’Argenio, A., Nilo, R., Fedele, M., Camorani, S., & Cerchia, L. (2023) · Cancers · doi:10.3390/cancers15072010 · Cited by 26
Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics
White, M. E. H., Sinn, L. R., Jones, D. M., de Folter, J., Aulakh, S. K., Wang, Z., Flynn, H. R., Krüger, L., Tober‐Lau, P., Demichev, V., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01067-5 · Cited by 31
Electrochemical aptasensors for detection of small molecules, macromolecules, and cells
Han, K., Liu, T., Wang, Y., & Miao, P. (2016) · Reviews in Analytical Chemistry · doi:10.1515/revac-2016-0009 · Cited by 27
Trausch, J. J., Shank-Retzlaff, M. L., & Verch, T. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04852 · Cited by 26
Selecting Fully‐Modified XNA Aptamers Using Synthetic Genetics
Taylor, A. I., & Holliger, P. (2018) · Current Protocols in Chemical Biology · doi:10.1002/cpch.44 · Cited by 28
Immobilization of Aptamers on Substrates
Girolamo, A. D., McKeague, M., Pascale, M., Cortese, M., & DeRosa, M. C. (2018) · Wiley eBooks · doi:10.1002/9783527806799.ch3 · Cited by 31
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia
Giudice, V., Biancotto, A., Wu, Z., Cheung, F., Candia, J., Fantoni, G., Kajigaya, S., Rios, O., Townsley, D., Feng, X., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.09.008 · Cited by 25
Brown, A., Brill, J., Amini, R., Nurmi, C., & Li, Y. (2024) · Angewandte Chemie · doi:10.1002/ange.202318665 · Cited by 32
Nuclease-assisted selection of slow-off rate aptamers
Alkhamis, O., Canoura, J., Wang, L., & Xiao, Y. (2024) · Science Advances · doi:10.1126/sciadv.adl3426 · Cited by 25
Wang, S., Rao, Z., Cao, R., Blaes, A. H., Coresh, J., Deo, R., Dubin, R. F., Joshu, C. E., Lehallier, B., Lutsey, P. L., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004464 · Cited by 28
Advances in aptamer technology for target-based drug discovery
Cui, Y., Chen, Y., Zhang, Y.-B., & Zhang, L. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101369 · Cited by 32
Huynh, T., Sun, B., Li, L., Nichols, K. P., Koyner, J. L., & Ismagilov, R. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4062882 · Cited by 29
Aptamers for Targeted Delivery: Current Challenges and Future Opportunities
Chandola, C., & Neerathilingam, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84217 · Cited by 25
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
Smith, M. A., Chiang, C.-C., Zerrouki, K., Rahman, S., White, W. I., Streicher, K. L., Rees, W. A., Schiffenbauer, A. I., Rider, L. G., Miller, F. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60563-9 · Cited by 25
Analytical approaches to differential extraction for sexual assault evidence
Clark, C., Turiello, R., Cotton, R. W., & Landers, J. P. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.07.059 · Cited by 31
Highly Sensitive Protein Detection by Aptamer-Based Single-MoleculePreprint
Chatterjee, T., Johnson-Buck, A. E., & Walter, N. G. (2022) · SSRN Electronic Journal · doi:10.1016/j.bios.2022.114639 · Cited by 25
Human Plasma Proteome During Normal Pregnancy
Tarca, A. L., Romero, R. J., Bhatti, G., Gotsch, F., Done, B., Gudicha, D. W., Gallo, D. M., Jung, E., Piqué-Regi, R., Berry, S. M., et al. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00391 · Cited by 28
Aptamer-based applications for cardiovascular disease
Chen, X., Ma, Y., Xie, Y., & Pu, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1002285 · Cited by 27
Abdi, I. Y., Bartl, M., Dakna, M., Abdesselem, H., Majbour, N. K., Trenkwalder, C., El‐Agnaf, O. M. A., & Mollenhauer, B. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.105997 · Cited by 29
Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
Sanati, M., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., & Sahebkar, A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166720 · Cited by 29
The Expanded Central Dogma: Genome Resynthesis, Orthogonal Biosystems, Synthetic Genetics
Gerecht, K., Freund, N., Liu, W., Liu, Y., Fürst, M. J. L. J., & Holliger, P. (2023) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-111622-091203 · Cited by 30
Tonelli, R. R., Colli, W., & Alves, M. (2012) · Front. Immun. · doi:10.3389/fimmu.2012.00419 · Cited by 47
Zhao, Q., & Gao, J. (2013) · Chemical Communications · doi:10.1039/c3cc44400g · Cited by 25
Synthetic genetic polymers: advances and applications
Ma, Q., Lee, D., Tan, Y. Q., Wong, G. B., & Gao, Z. (2016) · Polymer Chemistry · doi:10.1039/c6py01075j · Cited by 27
van den Broek, T. J., Kremer, B. H. A., Rezende, M. M., Hoevenaars, F. P. M., Weber, P., Hoeller, U., van Ommen, B., & Wopereis, S. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0553-7 · Cited by 27
Aptahistochemistry in diagnostic pathology: technical scrutiny and feasibility
Bukari, B. A., Citartan, M., Ch’ng, E. S., Bilibana, M. P., Rozhdestvensky, T. S., & Tang, T. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1561-9 · Cited by 25
Serum proteomic assessment of the progression of fracture healing
Hussein, A. I., Mancini, C., Lybrand, K. E., Cooke, M. E., Matheny, H. E., Hogue, B., Tornetta, P., & Gerstenfeld, L. C. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23754 · Cited by 26
In Vitro Selection and Characterization of DNA Aptamers to a Small Molecule Target
Ruscito, A., McConnell, E. M., Koudrina, A., Velu, R., Mattice, C., Hunt, V., McKeague, M., & DeRosa, M. C. (2017) · Current Protocols in Chemical Biology · doi:10.1002/cpch.28 · Cited by 25
Lee, K., Nojoomi, A., Jeon, J., Lee, C. Y., & Yum, K. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b01377 · Cited by 26
Kuku, K. O., Shearer, J. J., Hashemian, M., Oyetoro, R. O., Park, H., Dulek, B., Bielinski, S. J., Larson, N. B., Ganz, P., Levy, D. A., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2328 · Cited by 25
A microbiome-directed therapeutic food for children recovering from severe acute malnutrition
Hartman, S. J., Hibberd, M. C., Mostafa, I., Naila, N. N., Islam, M. M., Zaman, M. U., Huq, S., Mahfuz, M., Islam, M. T., Mukherji, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn2366 · Cited by 30
Systems Human Immunology and AI: Immune Setpoint and Immune Health
Lei, Y., & Tsang, J. S. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-042631 · Cited by 31
Cayer, D. M., Nazor, K. L., & Schork, N. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw214 · Cited by 29
A Receptor‐Guided Design Strategy for Ligand Identification
Rosenthal, M., Pfeiffer, F., & Mayer, G. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903479 · Cited by 29
Minagawa, H., Shimizu, A., Kataoka, Y., Kuwahara, M., Kato, S., Horii, K., Shiratori, I., & Waga, I. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03450 · Cited by 26
A high affinity modified DNA aptamer containing base-appended bases for human β-defensin
Minagawa, H., Kataoka, Y., Kuwahara, M., Horii, K., Shiratori, I., & Waga, I. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113627 · Cited by 24
Lynch, A. M., Wagner, B. D., Palestine, A. G., Janjić, N., Patnaik, J. L., Mathias, M. T., Siringo, F. S., & Mandava, N. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.10.12 · Cited by 25
Proteomic assessment of serum biomarkers of longevity in older men
ORWOLL, E. S., Wiedrick, J. T., Nielson, C. M., Jacobs, J., Baker, E. S., Piehowski, P., Petyuk, V., Gao, Y., Shi, T., Smith, R. D., et al. (2020) · Aging Cell · doi:10.1111/acel.13253 · Cited by 23
Degnes, M.-H. L., Westerberg, A. C., Zucknick, M., Powell, T. L., Jansson, T., Henriksen, T., Roland, M. C. P., & Michelsen, T. M. (2022) · BMC Medicine · doi:10.1186/s12916-022-02415-z · Cited by 26
Austin, T. R., McHugh, C., Brody, J. A., Bis, J. C., Sitlani, C. M., Bartz, T. M., Biggs, M. L., Bansal, N., Bůžková, P., Carr, S. A., et al. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00888-z · Cited by 26
Mulholland, C., Jestřábová, I., Sett, A., Ondruš, M., Sýkorová, V., Manzanares‐Palenzuela, C. L., Šimončík, O., Müller, P., & Hocek, M. (2023) · Communications Chemistry · doi:10.1038/s42004-023-00862-0 · Cited by 27
Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema
Suryadevara, R., Gregory, A., Lu, R. A., Xu, Z., Masoomi, A., Lutz, S. M., Berman, S., Yun, J. H., Saferali, A., Ryu, M. H., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0067oc · Cited by 28
Activation of Inflammatory and Pro-Thrombotic Pathways in Acute Stress Cardiomyopathy
Fitzgibbons, T. P., Edwards, Y. J. K., Shaw, P., Iskandar, A., Ahmed, M., Bote, J., Shah, T., Sinha, S., Gerszten, R. E., Keaney, J. F., et al. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00049 · Cited by 24
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.